Reig Jofre announces relevant shareholder. The Swiss investment fund Quaero Capital has recognized this Wednesday a position equivalent to 3.034% of the share capital of the Spanish pharmaceutical company. A position that reaches a valuation of 7.3 million euros at market prices.
The communication sent to the National Securities Market Commission (CNMV) indicates that the 3% threshold was exceeded on February 16. This is the level from which the supervisor considers a relevant investor in the shareholding of a company. Nevertheless, no further details about the operation.
The fund states that this position is direct through the Quaero Capital Funds (Lux) – Argonaut fund. Specific, counts in its portfolio 2.35 million shares of the Spanish companywhich has accumulated a decline of 3% so far this year.
With their position, the Swiss are placed as fourth reference shareholders by Reig Jofre. The company itself owns 62.72% of its capital as a result of the natraceutical absorption through which the Catalan debuted on the stock market.
Then, the next position is for the businessman Juan Ignacio López Gandasegui, who accumulates 10.11% of the capital. For its part, the Ybarra family agglutinates 5.53% through its holding company Onchena investor.
Despite the fact that Quaero Capital has now entered the group of relevant shareholders of Reig Jofre for the first time, their investment relationship dates back to 2019. Then, the Swiss firm participated for an undisclosed amount in the accelerated capital increase aimed at institutional investors in which it raised 24 million euros for its international expansion.